Scott J Antonia Clinical Oncology Society of Australia 2014 Annual Scientific Meeting

Abstracts this author is presenting:

• Nivolumab and ipilimumab in first-line non-small-cell lung carcinoma (NSCLC): interim phase I results — Poster discussion 1